A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial

SS Birring; Marlies Wijsenbeek - Lourens; S Agrawal; JWK van den Berg; H Stone; TM Maher; A Tutuncu; AH Morice

doi:10.1016/s2213-2600(17)30310-7

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial

SS Birring, Marlies Wijsenbeek - Lourens, S Agrawal, JWK van den Berg, H Stone, TM Maher, A Tutuncu, AH Morice

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

75 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	806-815
Number of pages	10
Journal	The Lancet Respiratory Medicine
Volume	5
Issue number	10
DOIs	https://doi.org/10.1016/s2213-2600(17)30310-7
Publication status	Published - 2017

Access to Document

10.1016/s2213-2600(17)30310-7

http://hdl.handle.net/1765/101867

Cite this

Birring, SS., Wijsenbeek - Lourens, M., Agrawal, S., van den Berg, JWK., Stone, H., Maher, TM., Tutuncu, A., & Morice, AH. (2017). A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. The Lancet Respiratory Medicine, 5(10), 806-815. https://doi.org/10.1016/s2213-2600(17)30310-7

@article{977ec218adab40bdadc5456b29716099,

title = "A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial",

author = "SS Birring and {Wijsenbeek - Lourens}, Marlies and S Agrawal and {van den Berg}, JWK and H Stone and TM Maher and A Tutuncu and AH Morice",

year = "2017",

doi = "10.1016/s2213-2600(17)30310-7",

language = "Undefined/Unknown",

volume = "5",

pages = "806--815",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Ltd.",

number = "10",

}

Birring, SS, Wijsenbeek - Lourens, M, Agrawal, S, van den Berg, JWK, Stone, H, Maher, TM, Tutuncu, A & Morice, AH 2017, 'A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial', The Lancet Respiratory Medicine, vol. 5, no. 10, pp. 806-815. https://doi.org/10.1016/s2213-2600(17)30310-7

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. / Birring, SS; Wijsenbeek - Lourens, Marlies; Agrawal, S et al.

In: The Lancet Respiratory Medicine, Vol. 5, No. 10, 2017, p. 806-815.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial

AU - Birring, SS

AU - Wijsenbeek - Lourens, Marlies

AU - Agrawal, S

AU - van den Berg, JWK

AU - Stone, H

AU - Maher, TM

AU - Tutuncu, A

AU - Morice, AH

PY - 2017

Y1 - 2017

U2 - 10.1016/s2213-2600(17)30310-7

DO - 10.1016/s2213-2600(17)30310-7

M3 - Article

VL - 5

SP - 806

EP - 815

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

SN - 2213-2600

IS - 10

ER -